Treatment-resistant systemic lupus erythematosus-associated hypocomplementic urticarial vasculitis successfully treated with belimumab.

Authors	Rodrigo Peñuelas Leal, Carolina Labrandero Hoyos, Felipe Partarrieu Mejías, Andrés Grau Echevarría, Javier Lorca Spröhnle, Andrés Casanova Esquembre, Altea Esteve Martínez, Violeta Zaragoza Ninet
Journal	The Australasian journal of dermatology (Australas J Dermatol) Vol. 64 Issue 2 Pg. 301-303 (05 2023) ISSN: 1440-0960 [Electronic] Australia
PMID	36745520 (Publication Type: Case Reports)
Chemical References	belimumab Antibodies, Monoclonal, Humanized
Topics	Humans Urticaria (drug therapy, etiology) Vasculitis (drug therapy) Antibodies, Monoclonal, Humanized (therapeutic use) Lupus Erythematosus, Systemic (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!